Lantheus Weighs $7 Billion Sale to Curium After Takeover Offer

1 articles · Updated · Bloomberg · May 22

Lantheus Holdings is considering a sale after receiving a Curium takeover offer that values the radiopharma company at about $7 billion, according to people familiar with the matter.
Curium and Lantheus have been in discussions on a potential deal that could be weeks away, though the talks remain private and no final decision has been made.
Any transaction is still uncertain, with the people cautioning there is no guarantee the negotiations will result in a deal.

Is Curium’s $7 billion offer a visionary move or a risky overpayment for a company facing slowing sales?

Can these giants merge fragile, radioactive supply chains without disrupting critical cancer treatments for patients worldwide?